Brimonidine/timolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Brimonidine/timolol
Combination of
Brimonidine α2 adrenergic agonist
Timolol Beta blocker
Clinical data
Trade names Combigan
AHFS/Drugs.com entry
Pregnancy cat.
Legal status
Routes Eye drops
Identifiers
ATC code S01ED51
PubChem CID 11387895

Brimonidine/timolol (INNs, trade name Combigan) are combination eye drops indicated for the treatment of glaucoma. It is a combination of brimonidine (an α2 adrenergic agonist) and timolol (a β adrenergic blocker), in concentrations of 0.2% and 0.5% respectively. Both substances work by decreasing the synthesis of aqueous humor.

Combigan is marketed and sold by Allergan.